CDK2 targeted protein degrader (Blueprint Medicines)

N/A

Report date: 2025/06/11 11:24:36
NME

Base Information

Drug NameCDK2 targeted protein degrader (Blueprint Medicines)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 2 inhibitorsAnticancer protein kinase inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsHR-positive breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlueprint Medicines Corp
China Registration ClassN/A

Develop Information

Active CompaniesBlueprint Medicines Corp
Inactive CompaniesN/A
Active IndicationsHR-positive breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A